A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

NCT06171113 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria, Falciparum

Interventions

DRUG: GSK4024484C
DRUG: Placebo

Sponsor

GlaxoSmithKline